Literature DB >> 24211534

Identification and characterization of the related immune-enhancing proteins in crab Scylla paramamosain stimulated with rhubarb polysaccharides.

Jingsong Cao1, Zehuan Wang, Yueling Zhang, Fengliang Qu, Lingling Guo, Mingqi Zhong, Shengkang Li, Haiying Zou, Jiehui Chen, Xiuying Wang.   

Abstract

Recently, considerable interest has been focused on immunostimulants to reduce diseases in crab aquaculture. However, information regarding to the related immune-enhancing proteins in crabs is not available yet. In this study, rhubarb polysaccharides were tested for enhancement of the immune activity in crab Scylla paramamosain. Compared with those in the control group, values of, phenoloxidase (PO), alkaline phosphatase (AKP) and alkaline phosphatasein (ACP) activity in the, experimental group were improved significantly 4 d after the treatment. Furthermore, 15 and 17 altered proteins from haemocytes and hepatopancreas, respectively, were found in rhubarb polysaccharide-treated crabs using 2-DE approach. Of these, hemocyanin, chymotrypsin, cryptocyanin, C-type lectin receptor, and ferritin protein were identified by mass spectrometry. In addition, RT-PCR, analysis showed that the mRNA levels of hemocyanin and chymotrypsin increased about 2.4- and 1.4-fold in the experiment group. Moreover, the hemocyanin gene in S. paramamosain (SpHMC) was, cloned and characterized. SpHMC contains one open reading frame of 2022 bp and encodes a polypeptide of 673 amino acids. It is clustered into one branch along with crab hemocyanin in a phylogenetic tree. The mRNA transcripts of SpHMC were detected mainly in the tissues of, hepatopancreas, hemocyte and intestines, and its levels were up-regulated significantly in hemocytes, of S. paramamosain treated with Vibrio parahemolyticus, Beta streptococcus or poly I:C for 6-48 h. Taken together, these studies found 5 related immune-enhancing proteins and a novel heomcyanin homologue with potential pathogen-resistant activities in crab.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hemocyanin; Immunostimulant; Pathogen-resistance; Related immune-enhancing proteins; Scylla paramamosain

Mesh:

Substances:

Year:  2013        PMID: 24211534     DOI: 10.1016/j.molimm.2013.10.003

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  C-Terminal Domain of Hemocyanin, a Major Antimicrobial Protein from Litopenaeus vannamei: Structural Homology with Immunoglobulins and Molecular Diversity.

Authors:  Yue-Ling Zhang; Bo Peng; Hui Li; Fang Yan; Hong-Kai Wu; Xian-Liang Zhao; Xiang-Min Lin; Shao-Ying Min; Yuan-Yuan Gao; San-Ying Wang; Yuan-You Li; Xuan-Xian Peng
Journal:  Front Immunol       Date:  2017-06-13       Impact factor: 7.561

2.  A Possible Role of Crustacean Cardioactive Peptide in Regulating Immune Response in Hepatopancreas of Mud Crab.

Authors:  Yujie Wei; Dongdong Lin; Zhanning Xu; Xiaoman Gao; Chaoshu Zeng; Haihui Ye
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

3.  Agavin induces beneficial microbes in the shrimp microbiota under farming conditions.

Authors:  Juan Pablo Ochoa-Romo; Fernanda Cornejo-Granados; Alonso A Lopez-Zavala; María Teresa Viana; Filiberto Sánchez; Luigui Gallardo-Becerra; Mirna Luque-Villegas; Yesenia Valdez-López; Rogerio R Sotelo-Mundo; Andrés Cota-Huízar; Agustín López-Munguia; Adrian Ochoa-Leyva
Journal:  Sci Rep       Date:  2022-04-16       Impact factor: 4.996

4.  Hemocyanin from Shrimp Litopenaeus vannamei Has Antiproliferative Effect against HeLa Cell In Vitro.

Authors:  Liyuan Zheng; Xianliang Zhao; Pei Zhang; Chuandao Chen; Shangjie Liu; Runqing Huang; Mingqi Zhong; Chiju Wei; Yueling Zhang
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

5.  Protein Diversity and Immune Specificity of Hemocyanin From Shrimp Litopenaeus vannamei.

Authors:  Xianliang Zhao; Jie Qiao; Pei Zhang; Zehui Zhang; Jude Juventus Aweya; Xiaohan Chen; Yongzhen Zhao; Yueling Zhang
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.